COVID-19 can have a serious impact effecting the heart during and after infection. The ACC released expert consensus decision pathway for the evaluation and management for the cardiovascular consequences of COVID infection and long-COVID, also known by its official clinical designation as post-acute sequelae of SARS-CoV-2 infection (PASC).

VIDEO: ACC Guidance on the cardiovascular impact of COVID-19

Ty Gluckman, MD, explains the main points of the American College of Cardiology (ACC) expert consensus on the cardiovascular consequences stemming from a COVID-19 infection.

Why cardiologists and radiologists are choosing cardiac CT over invasive angiography for suspected CAD

"A CT-first strategy allows physicians to provide relevant findings without the need for an invasive procedure," one radiologist explained. 

Leslee Shaw, PhD, and former presidents of both SCCT and ASNC discusses the role of CT and FFR-CT in the 2021 chest pain guidelines.

VIDEO: Cardiac CT now recommended as a front-line chest pain assessment tool

Leslee Shaw, PhD, director of the Blavatnik Family Women’s Health Research Institute at Mount Sinai Hospital in New York and former president of the Society of Cardiovascular Computed Tomography (SCCT) and the American Society of Nuclear Cardiology (ASNC), explains the role of cardiac computed tomography (CT) in the recent 2021 chest pain guidelines.

Edward Fry, MD, is the 2022-23 ACC president.

Q&A: New ACC President Edward Fry discusses the past, present and future of cardiology

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 

covid-19 money virus coronavirus dollar

American Heart Association awards $10.6M to researchers investigating the long-term cardiovascular effects of COVID-19

The grants went to 11 different research teams in the United States and are expected to fund these projects for three years.

The American College of Cardiology (ACC) annual meeting is the premier source for the latest cardiac science. #ACC22

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

VIDEO: TAVR durability outperforms surgical valves

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19.